Also with respect to sex hormone-binding globulin (SHGB), the majority of epidemiological studies demonstrated inverse associations with metabolic syndrome (MetS) or T2DM in women9 suggesting low SHBG as a potential risk marker for cardiometabolic morbidity, particularly among postmenopausal women9. This evidence concerns the gene SHBG and metabolic syndrome.